A drug discovery platform company focused on structural biology, medicinal chemistry and cell biology.

A drug discovery technology and services company. Completed $54 million IPO in 2000 and acquired by DeCODE genetics inc.

ALS_logo.jpg

A joint venture between MediChem and the Malaysian government developing HIV drugs.  Acquired by Malaysian government in 2006.

SMP_logo.jpg

A drug development company focused on infection, cancer and respiratory diseases. Completed $35 million IPO in 2005.

ALS_logo.jpg

Current Portfolio:

Past Investments: